174 related articles for article (PubMed ID: 32469446)
1. Dupilumab for treatment-refractory prurigo nodularis.
Kovács B; Rose E; Kuznik N; Shimanovich I; Zillikens D; Ludwig RJ; Thaçi D
J Dtsch Dermatol Ges; 2020 Jun; 18(6):618-624. PubMed ID: 32469446
[No Abstract] [Full Text] [Related]
2. Dupilumab for pediatric prurigo nodularis: A case report.
Fachler T; Maria Faitataziadou S; Molho-Pessach V
Pediatr Dermatol; 2021 Jan; 38(1):334-335. PubMed ID: 33247435
[TBL] [Abstract][Full Text] [Related]
3. Dupilumab treatment of prurigo nodularis in an adolescent.
Giovannini M; Mori F; Oranges T; Ricci S; Barni S; Canessa C; Liccioli G; Lodi L; Sarti L; Novembre E; Azzari C; Filippeschi C
Eur J Dermatol; 2021 Feb; 31(1):104-106. PubMed ID: 33586661
[No Abstract] [Full Text] [Related]
4. Safety and Effectiveness of Dupilumab in Prurigo Nodularis.
Romano C
J Investig Allergol Clin Immunol; 2021 Apr; 31(2):162-163. PubMed ID: 32573461
[No Abstract] [Full Text] [Related]
5. Dramatic improvement of generalized prurigo nodularis with dupilumab.
Calugareanu A; Jachiet M; Lepelletier C; De Masson A; Rybojad M; Bagot M; Bouaziz JD
J Eur Acad Dermatol Venereol; 2019 Aug; 33(8):e303-e304. PubMed ID: 30893496
[No Abstract] [Full Text] [Related]
6. Dupilumab as a novel treatment option for prurigo nodularis.
Nakajima S; Yonekura S; Nakamizo S; Egawa G; Kabashima K
J Allergy Clin Immunol; 2023 Oct; 152(4):870-872. PubMed ID: 37625462
[No Abstract] [Full Text] [Related]
7. Dupilumab: A Safe and Successful Treatment in Refractory Prurigo Nodularis.
Cunha IM; Valadão I; Gomes E; Marinho A
J Allergy Clin Immunol Pract; 2022 May; 10(5):1365-1366. PubMed ID: 35331683
[No Abstract] [Full Text] [Related]
8. Dupilumab for the Treatment of Prurigo Nodularis.
Alkhaleefa A; Woo TE; Parsons L
Skin Therapy Lett; 2023 Nov; 28(6):7-9. PubMed ID: 38016088
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness and safety of dupilumab for the treatment of prurigo nodularis in a French multicenter adult cohort of 16 patients.
Calugareanu A; Jachiet M; Tauber M; Nosbaum A; Aubin F; Misery L; Droitcourt C; Barbarot S; Debarbieux S; Saussine A; Bagot M; de Masson A; Sénéschal J; Staumont-Sallé D; Bouaziz JD;
J Eur Acad Dermatol Venereol; 2020 Feb; 34(2):e74-e76. PubMed ID: 31529718
[No Abstract] [Full Text] [Related]
10. A critical review of dupilumab for adult patients with prurigo nodularis.
Biazus Soares G; Yosipovitch G
Expert Rev Clin Immunol; 2024 Mar; 20(3):249-254. PubMed ID: 37811660
[TBL] [Abstract][Full Text] [Related]
11. Dupilumab for prurigo nodularis: Case series and review of the literature.
Holm JG; Agner T; Sand C; Thomsen SF
Dermatol Ther; 2020 Mar; 33(2):e13222. PubMed ID: 31917498
[TBL] [Abstract][Full Text] [Related]
12. Emerging treatment of prurigo nodularis with dupilumab.
Humpel O; Fill L; Hostoffer R
J Osteopath Med; 2023 Oct; 123(11):555-556. PubMed ID: 37540840
[No Abstract] [Full Text] [Related]
13. Efficacy of dupilumab in prurigo nodularis in elderly patient.
Giura MT; Viola R; Fierro MT; Ribero S; Ortoncelli M
Dermatol Ther; 2020 Jan; 33(1):e13201. PubMed ID: 31856368
[TBL] [Abstract][Full Text] [Related]
14. Dupilumab as a useful treatment option for prurigo nodularis in an elderly patient with atopic diathesis.
Criado PR; Pincelli TP; Criado RFJ
Int J Dermatol; 2020 Oct; 59(10):e358-e361. PubMed ID: 32562425
[No Abstract] [Full Text] [Related]
15. Learning from nemolizumab: A promising therapy for prurigo nodularis.
Kim BS
J Allergy Clin Immunol; 2024 Jun; 153(6):1548-1549. PubMed ID: 38460679
[No Abstract] [Full Text] [Related]
16. Dupilumab for a 5-year-old child with prurigo nodularis.
Chia-Jen L; Yun-Chang L; Hui-Chin C; Yu-Ping H
J Dtsch Dermatol Ges; 2023 Dec; 21(12):1563-1565. PubMed ID: 37875782
[No Abstract] [Full Text] [Related]
17. Dupilumab for the treatment of prurigo nodularis: A systematic review.
Cao P; Xu W; Jiang S; Zhang L
Front Immunol; 2023; 14():1092685. PubMed ID: 36742321
[TBL] [Abstract][Full Text] [Related]
18. Baseline eosinophil level may be a predictive indicator for the effectiveness of dupilumab in patients with prurigo nodularis: A single-center, real-world prospective study.
Yi X; Cao Q; Peng C; Jia Q; Li J
J Am Acad Dermatol; 2024 May; 90(5):1076-1078. PubMed ID: 38296194
[No Abstract] [Full Text] [Related]
19. Role of dupilumab in pediatric prurigo nodularis: Beyond the skin.
Oliveira J; Nogueira M; Pinto D; Machado S; Araújo AR; Teixeira F
Pediatr Allergy Immunol; 2023 Jan; 34(1):e13912. PubMed ID: 36705041
[No Abstract] [Full Text] [Related]
20. Ustekinumab plus dupilumab in the treatment of concomitant psoriasis and prurigo nodularis.
Kabbani M; Mboyo Mpita G; Benhadou F
J Eur Acad Dermatol Venereol; 2022 Dec; 36(12):e1050-e1051. PubMed ID: 35857380
[No Abstract] [Full Text] [Related]
[Next] [New Search]
